Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial - Quiz - MDSpire

Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial

  • By

  • Richard E. Pratley

  • Douglas Scott Denham

  • Rupal Trivedi

  • Elaine Watkins

  • Lisa Connery

  • Jennifer Barnes

  • Dongzi Yu

  • Janet Hong

  • Christopher Simard

  • Kimberly Umans

  • Lan Liu

  • Giridhar S. Tirucherai

  • Jing L. Marantz

  • June 8, 2026

  • 0 min

Share

Original Source(s)

Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial

  • by Richard E. Pratley, Douglas Scott Denham, Rupal Trivedi, Elaine Watkins, Lisa Connery, Jennifer Barnes, Dongzi Yu, Janet Hong, Christopher Simard, Kimberly Umans, Lan Liu, Giridhar S. Tirucherai, Jing L. Marantz

  • June 8, 2026

Related Content

Sleep Study Cutoffs May Guide Discharge

Preoperative sleep study values may distinguish lower-risk children within a population for whom overnight admission is currently routine.

Association Between Edmonton Obesity Staging System Severity and 90-Day Postoperative Complications After Primary Metabolic and Bariatric Surgery: A Retrospective Cohort Study

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study